繁
简
Market+ (iPhone)
Market+ (Android)
Mobile Site
US STOCKS
FUNDS
FX & CRYPTO
SH/SZ-HK
HK STOCKS
 
 
 
 
 
 
Quote Service
Market
Market
Quotes
Quotes
Analysis
Analysis
Commentary
Commentary
Warrants&CBBCs
Warrants&CBBCs
Warrants&CBBCs Overview
Warrants
CBBCs
ETF
ETF
MPF
MPF
Education
Members
Members
About Us
About Us

ETF Overview

TRACKER FUND
ISHARES A50
HSCEI ETF
CSOP A50 ETF
CAM CSI300
Last (HKD)1
Details»
Vol. 
Turn. 
Range
NAV (HKD)
Premium%
1-Month Range
2-Month Range
3-Month Range
52-Week Range
1D
1M
Advanced Chart
ETF Overview
Issuer
Expenses & Facts
Analysis
Calendar Yr Chg
Cumulative Chg
Overview (By Turn.)
Overview (By Asset)
Name/ Symbol
Underlying Asset
Last1
Chg
Chg%
Vol.
Turn.
NAV (Premium%)
Chart
Compare
TRACKER FUND
 Hang Seng Index 18.720
 HKD 		+0.370 +2.016% 445.54M 8.32B 18.369 (+1.912%)
HKD as at 2024/09/17
HSCEI ETF
 Hang Seng China Enterprises 65.340
 HKD 		+1.420 +2.222% 73.10M 4.77B 63.896 (+2.260%)
HKD as at 2024/09/17
CSOP HS TECH
 Hang Seng TECH Index 3.590
 HKD 		+0.112 +3.220% 427.20M 1.53B 3.478 (+3.232%)
HKD as at 2024/09/17
XL2CSOPHSTECH
+2x
Leveraged Products typically aim to deliver a daily return equivalent to a multiple of the underlying index return that they track. Leveraged Products seeking SFC authorisation shall be subject to a maximum leverage factor of two times (2x).
 Hang Seng TECH Index 3.136
 HKD 		+0.198 +6.739% 351.46M 1.08B 2.942 (+6.583%)
HKD as at 2024/09/17
XI2CSOPHSTECH
-2x
Inverse Products typically aim to deliver the opposite of the daily return of the underlying index that they track. Inverse Products seeking SFC authorisation shall be subject to a maximum leverage factor of one time (-1x); Inverse Products cannot be leveraged.
 Hang Seng TECH Index 5.830
 HKD 		-0.395 -6.345% 161.21M 962.59M 6.241 (-6.582%)
HKD as at 2024/09/17
FI2 CSOP HSI
-2x
Inverse Products typically aim to deliver the opposite of the daily return of the underlying index that they track. Inverse Products seeking SFC authorisation shall be subject to a maximum leverage factor of one time (-1x); Inverse Products cannot be leveraged.
 Hang Seng Index 4.940
 HKD 		-0.205 -3.984% 119.16M 595.31M 5.153 (-4.132%)
HKD as at 2024/09/17
FL2 CSOP HSI
+2x
Leveraged Products typically aim to deliver a daily return equivalent to a multiple of the underlying index return that they track. Leveraged Products seeking SFC authorisation shall be subject to a maximum leverage factor of two times (2x).
 Hang Seng Index 3.314
 HKD 		+0.132 +4.148% 108.75M 354.47M 3.182 (+4.145%)
HKD as at 2024/09/17
ISHARESHSTECH
 Hang Seng TECH Index 7.685
 HKD 		+0.240 +3.224% 18.72M 142.79M 7.449 (+3.174%)
HKD as at 2024/09/17
HSTECH ETF
 Hang Seng TECH Index 3.632
 HKD 		+0.116 +3.299% 15.31M 55.13M 3.522 (+3.117%)
HKD as at 2024/09/17
FI2CSOPNASDAQ
-2x
Inverse Products typically aim to deliver the opposite of the daily return of the underlying index that they track. Inverse Products seeking SFC authorisation shall be subject to a maximum leverage factor of one time (-1x); Inverse Products cannot be leveraged.
 NASDAQ-100 Index 5.735
 HKD 		-0.120 -2.050% 8.96M 52.03M 5.892 (-2.658%)
HKD as at 2024/09/17
SPDR GOLD TRUST
 London Gold Fixing Price 1,861.500
 HKD 		+2.500 +0.134% 23.29K 43.04M 1,851.465 (+0.542%)
HKD as at 2024/09/18
CAM CSI300
 CSI 300 36.440
 HKD 		+0.420 +1.166% 1.16M 42.25M 35.850 (+1.645%)
HKD as at 2024/09/16
FL2 CSOP HSCEI
+2x
Leveraged Products typically aim to deliver a daily return equivalent to a multiple of the underlying index return that they track. Leveraged Products seeking SFC authorisation shall be subject to a maximum leverage factor of two times (2x).
 Hang Seng China Enterprises 1.970
 HKD 		+0.084 +4.454% 18.94M 36.94M 1.889 (+4.294%)
HKD as at 2024/09/17
CSOP A50 ETF
 FTSE China A50 11.350
 HKD 		+0.050 +0.442% 3.11M 35.19M 11.245 (+0.935%)
HKD as at 2024/09/17
ISHARES A50
 FTSE China A50 12.070
 HKD 		+0.060 +0.500% 1.93M 23.18M 11.897 (+1.454%)
HKD as at 2024/09/17
GX HS HIGH DIV
 Hang Seng High Dividend Yield 22.320
 HKD 		+0.300 +1.362% 1.05M 23.17M 22.004 (+1.437%)
HKD as at 2024/09/17
FL2CSOPGOLD
+2x
Leveraged Products typically aim to deliver a daily return equivalent to a multiple of the underlying index return that they track. Leveraged Products seeking SFC authorisation shall be subject to a maximum leverage factor of two times (2x).
 Solactive Gold 1-Day Rolling Futures Index 11.410
 HKD 		+0.010 +0.088% 1.70M 19.15M 11.262 (+1.313%)
HKD as at 2024/09/17
FI2 CSOP NIKKEI
-2x
Inverse Products typically aim to deliver the opposite of the daily return of the underlying index that they track. Inverse Products seeking SFC authorisation shall be subject to a maximum leverage factor of one time (-1x); Inverse Products cannot be leveraged.
 Nikkei Stock Average Index 79.900
 HKD 		-5.580 -6.528% 226.56K 18.08M 85.487 (-6.536%)
HKD as at 2024/09/17
CAM BTC
 CME CF Bitcoin Reference Rate- Asia Pacific Variant 7.720
 HKD 		+0.430 +5.898% 1.93M 14.86M 7.280 (+6.041%)
HKD as at 2024/09/17
CSOP UST20
 FTSE US Treasury 20+ Years Index 78.860
 HKD 		-1.000 -1.252% 178.96K 14.06M 79.375 (-0.649%)
HKD as at 2024/09/17
ISHARES CHINA
 MSCI China 18.750
 HKD 		+0.670 +3.706% 764.20K 13.99M 18.089 (+3.654%)
HKD as at 2024/09/17
FA CSOP BTC
 CME Bitcoin Futures 22.960
 HKD 		+1.260 +5.806% 572.10K 13.11M 22.157 (+3.626%)
HKD as at 2024/09/17
FI2 CSOP HSCEI
-2x
Inverse Products typically aim to deliver the opposite of the daily return of the underlying index that they track. Inverse Products seeking SFC authorisation shall be subject to a maximum leverage factor of one time (-1x); Inverse Products cannot be leveraged.
 Hang Seng China Enterprises 4.218
 HKD 		-0.186 -4.223% 2.34M 10.12M 4.408 (-4.306%)
HKD as at 2024/09/17
XL2CSOPCSI300
+2x
Leveraged Products typically aim to deliver a daily return equivalent to a multiple of the underlying index return that they track. Leveraged Products seeking SFC authorisation shall be subject to a maximum leverage factor of two times (2x).
 CSI 300 2.774
 HKD 		+0.030 +1.093% 2.56M 7.09M 2.670 (+3.887%)
HKD as at 2024/09/17
CAM CSI300-R
 CSI 300 33.100
 CNY 		+0.240 +0.730% 199.30K 6.58M 32.657 (+1.357%)
CNY as at 2024/09/16
FI2CAMNDQ100
-2x
Inverse Products typically aim to deliver the opposite of the daily return of the underlying index that they track. Inverse Products seeking SFC authorisation shall be subject to a maximum leverage factor of one time (-1x); Inverse Products cannot be leveraged.
 NASDAQ-100 Index 0.865
 HKD 		-0.017 -1.927% 7.20M 6.32M 0.889 (-2.700%)
HKD as at 2024/09/17
CAM HSI ESG
 HSI ESG Enhanced Index (net total return index) 37.240
 HKD 		+0.860 +2.364% 160.00K 5.97M 36.477 (+2.093%)
HKD as at 2024/09/17
F SAMSUNG OIL
 S&P GSCI Crude Oil Index Excess Return 6.600
 HKD 		+0.140 +2.167% 895.20K 5.85M 6.533 (+1.032%)
HKD as at 2024/09/17
GX ASIA SEMICON
 FactSet Asia Semiconductor Index (net total return) 54.640
 HKD 		-0.420 -0.763% 106.91K 5.80M 54.849 (-0.380%)
HKD as at 2024/09/17
ISHARESHSI
 Hang Seng Index (net total return version) 67.220
 HKD 		+1.420 +2.158% 81.95K 5.47M 65.762 (+2.217%)
HKD as at 2024/09/17
(1) All quotes for Hong Kong Stocks are at least 15 minutes delayed. Last Updated: 2024/09/19 16:08
 
SITEMAP
AASTOCKS.com
 
 
Members
 
About Us
Market
Quotes
 
Analysis
News & Research
 
Commentary
 
Warrants&CBBCs
 
Warrants
 
CBBCs
 
US Stocks
Forex
 
Fund
 
MPF
Email: support@aastocks.com
AASTOCKS.COM LIMITED (阿斯達克網絡信息有限公司) All rights reserved.
Disclaimer
AASTOCKS.COM LIMITED (阿斯達克網絡信息有限公司), HKEx Information Services Limited, its holding companies and/or any subsidiaries of such holding companies endeavour to ensure the accuracy and reliability of the Information provided but do not guarantee its accuracy or reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.

The above is strictly for information purposes only and should not be considered an offer, or solicitation, to deal in any of the mentioned funds. Investment involves risk, emerging markets may have greater risk than developed markets. Subscriptions may only be made on the basis of the relevant offering documents, most recent annual financial statement and semi-annual financial statements if published thereafter. The value of investments and the income received from them (if any) may be volatile and could change substantially within a short period of time. Past performance is not a guide to future performance. The investment returns are denominated in the base currency of the fund. US dollar / HK dollar based investors are therefore exposed to fluctuations in the US dollar / HK dollar / base currency exchange rate.

BEFORE MAKING AN INVESTMENT, YOU SHOULD REFER TO THE RELEVANT OFFERING DOCUMENTS AND IN PARTICULAR TO THE INVESTMENT POLICIES AND THE RISK FACTORS. YOU SHOULD ENSURE THAT YOU FULLY UNDERSTAND THE RISKS ASSOCIATED WITH THE FUND AND SHOULD ALSO CONSIDER YOUR OWN INVESTMENT OBJECTIVE AND RISK TOLERANCE LEVEL. YOU ARE REMINDED THAT YOU ARE RESPONSIBLE FOR YOUR INVESTMENT DECISION AND SHOULD NOT INVEST UNLESS THE INTERMEDIARY WHO OFFERS OR SELLS THE FUND TO YOU HAS ADVISED THAT THE FUND IS SUITABLE FOR YOU AND HAS EXPLAINED WHY, INCLUDING HOW BUYING THE FUND WOULD BE CONSISTENT WITH YOUR INVESTMENT OBJECTIVE. IF IN DOUBT, PLEASE SEEK INDEPENDENT FINANCIAL AND PROFESSIONAL ADVICE.

The information and products contained within this website are restricted to investors within Hong Kong. There are important legal and regulatory restrictions which apply to this website. These are laid out in the Disclaimer section which you are advised to read before proceeding. By proceeding, you are representing that you have understood and accepted the restrictions set out in the Disclaimer section.

Third party websites provided by hyperlinks on this website are completely beyond the control of AASTOCKS. Accordingly, AASTOCKS accepts no responsibility for the accuracy, completeness and legality of the contents of such third party website, or for any offers, services and products contained therein.

Remarks: All HK and China Indices are real time. World indices are at least 30 – 60 minutes delayed.
 
 
 
ETF Comparison
1
2
Compare